ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,274Medicare Part D Prescriptions Filled, Including Refills

Rank: 386 out of 2343

$678K Total Retail Price of All Prescriptions

Rank: 350 out of 2343

378 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 378 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 378 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 10,450 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 475 469 1 1
LEVOTHYROXINE SODIUM 472 431 2 2
FUROSEMIDE 463 447 3 6
OMEPRAZOLE 425 395 4 4
AMLODIPINE BESYLATE 423 396 5 5
WARFARIN SODIUM 335 335 6 8
METOPROLOL TARTRATE 311 301 7 7
LISINOPRIL 271 266 8 3
METOPROLOL SUCCINATE 233 225 9 14
ATENOLOL 195 191 10 12
CITALOPRAM HBR 173 169 11 17
ATORVASTATIN CALCIUM 153 136 12 10
DIGOXIN 134 134 13 35
DONEPEZIL HCL 130 130 14 21
TRAMADOL HCL 127 127 15 25
HYDROCODONE-ACETAMINOPHEN 124 95 S3 16 13
METFORMIN HCL 114 98 17 9
AZITHROMYCIN 114 105 17 39
CLOPIDOGREL 109 101 19 26
ISOSORBIDE MONONITRATE ER 106 106 20 32
KLOR-CON M20 101 101 21 44
SERTRALINE HCL 99 99 22 20
HYDROCHLOROTHIAZIDE 95 72 23 11
PANTOPRAZOLE SODIUM 92 87 24 22
KLOR-CON M10 89 89 25 107
NEXIUM 84 84 26 33
NAMENDA 83 83 27 36
CRESTOR 80 72 28 30
PLAVIX 79 72 29 38
RISPERIDONE 76 64 30 61
ALENDRONATE SODIUM 74 74 31 28
GLIPIZIDE 72 59 32 56
CELEBREX 70 70 33 71
DIOVAN 70 70 33 23
PREDNISONE 69 66 35 37
ADVAIR DISKUS 69 69 35 34
VENLAFAXINE HCL ER 68 68 37 87
ZETIA 67 67 38 52
FENTANYL 66 54 S2 39 69
GLIPIZIDE XL 65 59 40 84
GABAPENTIN 65 61 40 16
POTASSIUM CHLORIDE 61 49 42 18
BYSTOLIC 60 57 43 123
AMLODIPINE BESYLATE-BENAZEPRIL 57 57 44 59
ZOLPIDEM TARTRATE 54 47 45 24
JANUVIA 54 54 45 50
LANTUS 54 54 45 51
LOSARTAN POTASSIUM 54 50 45 19
GLIPIZIDE ER 54 53 45 115
CYMBALTA 53 53 50 74
NIFEDICAL XL 53 53 50 148
LIPITOR 51 46 52 78
METFORMIN HCL ER 50 50 53 88
ENALAPRIL MALEATE 50 47 53 58
POLYETHYLENE GLYCOL 3350 50 41 53 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.